Christine Pellizzari

Ms. Pellizzari has served as Science 37’s Chief Legal Officer since 2021, previously serving at Insmed since 2013, and most recently as Chief Legal Officer. She brings over 20 years of leadership in the global biopharmaceutical industry. Prior to Insmed, Ms. Pellizzari served as Executive Vice President, General Counsel, and Secretary of Aegerion Pharmaceuticals, Inc., where she oversaw all legal aspects of the company’s successful IPO and secondary public offering and served as a member of the Executive Management Committee. Prior to Aegerion, Ms. Pellizzari served as Senior Vice President, General Counsel, and Secretary of Dendrite International, Inc., a publicly traded company that provided sales effectiveness, promotional, and compliance solutions to the pharmaceutical industry. As a member of the company’s management team, she led many critical initiatives including the sale of the company to Cegedim S.A. in 2007. Ms. Pellizzari joined Dendrite from the law firm of Wilentz, Goldman & Spitzer where she specialized in health care transactions and related regulatory matters. She previously served as a law clerk to the Honorable Reginald Stanton, Assignment Judge for the Superior Court of New Jersey. Ms. Pellizzari received her Bachelor of Arts, cum laude, from the University of Massachusetts, Amherst, and her Juris Doctor degree from the University of Colorado, Boulder.